Deployment
Indego at Atlanta, Georgia, USA
Parker Hannifin's Indego is a powered lower-limb exoskeleton, FDA-cleared via 510(k) in 2016, intended to enable individuals with spinal cord injury at levels T7 to L5 to perform ambulatory functions with supervision of a specially trained companion.
Indego by Parker Hannifin Indego · Catalog entry · 1 source · not yet field-verified · Exoskeletons
Recent coverage
- Ekso Bionics acquires Human Motion and Control Business Unit, Indego product line from Parker Hannifin Corp. - Today's Medical DevelopmentsGoogle News · 2022-12-14
- Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M - MedTech DiveGoogle News · 2022-12-07
- Ekso Bionics buys Indego exoskeletons from Parker Hannifin - Medical Design & OutsourcingGoogle News · 2022-12-05
Shepherd Center in Atlanta served as Parker's lead clinical partner for Indego testing and training. Over 1,200 individual sessions conducted with no serious adverse events.
Safety record
No incidents on record for Indego at Atlanta, Georgia, USA.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
- Trust tier
- Catalog entry · 1 source · not yet field-verifiedhow tiers work →
- Last updated
- 2026-08-17
- Model
- Indego
- Company
- Parker Hannifin Indego
- Location
- Atlanta, Georgia, USA
- Operator
- Parker Hannifin Indego
- Status
- operational
- First seen
- 2014-09-01
- ID
5dd7224a-4372-444b-a68d-b12f9a1ec4c4
Timeline
- Sep 2014First recordedIndego first documented operating at Atlanta, Georgia, USA.
- Aug 2026Current status: operational, reviewedLatest recorded state. New status transitions append here as the deployment-status recorder produces them.
On the deployment map
Indego operates in Atlanta, Georgia, USA. Explore the full verified map:
Sources (1)
- FDA Clears Parker's Indego Exoskeleton for Clinical, Personal Use · https://investors.parker.com/news-events/press-releases/detail/190/fda-clears-parkers-indego-exoskeleton-for-clinical · 2014-09-01
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-08-17
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-17
Maturity + lifecycle
Maturity stage: research
Lifecycle: active
Architectural position
Cohort: exoskeleton
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Indego at Atlanta, Georgia, USA.Common questions
What is the Indego deployment at Atlanta, Georgia, USA?
Who operates Indego at Atlanta, Georgia, USA?
When did the Indego deployment at Atlanta, Georgia, USA go live?
Have there been incidents at the Indego deployment at Atlanta, Georgia, USA?
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.
Machine-readable surfaces
- Markdown mirror: /deployments/parker-indego-atlanta-georgia-usa.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/5dd7224a-4372-444b-a68d-b12f9a1ec4c4
- Data documentation: /data
- Query this programmatically: Deploy MCP